Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384473 · ClinicalTrials.gov registry record · Early Phase 1
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
A Early Phase 1 study, sponsored by University of Southern California.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT02384473 is a Early Phase 1 study that has completed, run by University of Southern California. The registered enrollment target is 25 participants.
The verdict
NCT02384473, a Early Phase 1 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This pilot clinical trial studies real-time contrast-enhanced ultrasonography and shear wave elastography in predicting treatment response in patients with soft tissue sarcomas. Ultrasonography and elastography are diagnostic imaging tests that use sound waves to make pictures of the body without using radiation (x-rays). Real-time contrast-enhanced ultrasonography and shear wave elastography may help measure a patient's response to treatment given before surgery in patients with soft tissue sarcoma.
Interventions
- DRUG Definity Suspension for Injection
- PROCEDURE Real-Time CEUS
- PROCEDURE SWE
- DEVICE Philips Shear Wave Elastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-12-24 |
| Est. Completion | 2024-01-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02384473
The ClinicalTrials.gov registry entry for NCT02384473 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Definity Suspension for Injection is the first listed.
NCT02384473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02384473 about?
NCT02384473 is a clinical study titled "Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma". This pilot clinical trial studies real-time contrast-enhanced ultrasonography and shear wave elastography in predicting treatment response in patients with soft tissue sarcomas. Ultrasonography and elastography are diagnostic imaging tests that use sound waves to make pictures of the body without us...
What is the current status of trial NCT02384473?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2014-12-24. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT02384473?
The interventions under investigation include: Definity Suspension for Injection (DRUG), Real-Time CEUS (PROCEDURE), SWE (PROCEDURE), Philips Shear Wave Elastography (DEVICE).
Who is sponsoring clinical trial NCT02384473?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.